Approach to the patient with hypogonadotropic hypogonadism

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 5, 2013, Pages 1781-1788

  Ferreira, Letícia ^a   Silveira, Gontijo ^a   Latronico, Ana Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; FIBROBLAST GROWTH FACTOR RECEPTOR 1; GONADORELIN; LUTEINIZING HORMONE;

ADULT; AMENORRHEA; ARTICLE; BODY HEIGHT; BONE AGE; BREAST DEVELOPMENT; CASE REPORT; CAVUS FEET; CLINICAL FEATURE; DELAYED PUBERTY; DEVELOPMENTAL SCREENING; ESTRADIOL BLOOD LEVEL; FEMALE; GENE DELETION; GONADORELIN TEST; HETEROZYGOTE DETECTION; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; LUTEINIZING HORMONE BLOOD LEVEL; NUCLEAR MAGNETIC RESONANCE IMAGING; OGIVAL PALATE; OSTEOPENIA; PHYSICAL EXAMINATION; PRECOCIOUS PUBERTY; PRIORITY JOURNAL;

ADULT; DIAGNOSIS, DIFFERENTIAL; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; HYPOGONADISM; PUBERTY, DELAYED; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SEQUENCE DELETION; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84877714923     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-3550     Document Type: Article

References (43)

1. Seminara SB, Hayes FJ, Crowley WF Jr. Gonadotropin-releasing hormone deficiency in the human (idiopathic hypogonadotropic hypogonadism and Kallmann's syndrome): pathophysiological and genetic considerations. Endocr Rev. 1998;19:521-539.
2. Silveira LF, MacColl GS, Bouloux PM. Hypogonadotropic hypogonadism. Semin Reprod Med. 2002;20:327-338.
3. Mitchell AL, Dwyer A, Pitteloud N, Quinton R. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol Metab. 2011;22:249-258.
4. Schwanzel-Fukuda M, Bick D, Pfaff DW. Luteinizing hormone-releasing hormone (LHRH)-expressing cells do not migrate normally in an inherited hypogonadal (Kallmann) syndrome. Brain Res Mol Brain Res. 1989;6:311-326.
5. Wray S, Grant P, Gainer H. Evidence that cells expressing luteinizing hormone-releasing hormone mRNA in the mouse are derived from progenitor cells in the olfactory placode. Proc Natl Acad Sci USA. 1989;86:8132-8136.
6. Quinton R, Duke VM, Robertson A, et al. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin Endocrinol (Oxf). 2001;55:163-174.
7. Fromantin M, Gineste J, Didier A, Rouvier J. [Impuberism and hypogonadism at induction into military service. Statistical study]. Probl Actuels Endocrinol Nutr. 1973;16:179-199.
8. Silveira LF, Trarbach EB, Latronico AC. Genetics basis for GnRH dependent pubertal disorders in humans. Mol Cell Endocrinol. 2010;324:30-38.
9. Young J, Metay C, Bouligand J, et al. SEMA3A deletion in a family with Kallmann syndrome validates the role of semaphorin 3A in human puberty and olfactory system development. Hum Reprod. 2012;27:1460-1465.
10. Semple RK, Topaloglu AK. The recent genetics of hypogonadotrophic hypogonadism-novel insights and new questions. Clin Endocrinol (Oxf). 2010;72:427-435.
11. Topaloglu AK, Tello JA, Kotan LD, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med. 2012; 366:629-635.
12. Pitteloud N, Quinton R, Pearce S, et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J Clin Invest. 2007;117:457-463.
13. Sykiotis GP, Plummer L, Hughes VA, et al. Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci USA. 2010;107:15140-15144.
14. Nachtigall LB, Boepple PA, Pralong FP, Crowley WF Jr. Adult-onset idiopathic hypogonadotropic hypogonadism-a treatable form of male infertility. N Engl J Med. 1997;336:410-415.
15. Dwyer AA, Hayes FJ, Plummer L, Pitteloud N, Crowley WF Jr. The long-term clinical follow-up and natural history of men with adultonset idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2010;95:4235-4243.
16. Wu FC, Tajar A, Beynon JM, et al. Identification of late-onset hypogonadism in middle-aged and elderly men. N Engl J Med. 2010; 363:123-135.
17. Tajar A, Huhtaniemi IT, O'Neill TW, et al. Characteristics of androgen deficiency in late-onset hypogonadism: results from the European Male Aging Study (EMAS). J Clin Endocrinol Metab. 2010; 97:1508-1516.
18. Santoro N, Filicori M, Crowley WF Jr. Hypogonadotropic disorders in men and women: diagnosis and therapy with pulsatile gonadotropin-releasing hormone. Endocr Rev. 1986;7:11-23.
19. Gordon CM. Clinical practice. Functional hypothalamic amenorrhea. N Engl J Med. 2010;363:365-371.
20. Caronia LM, Martin C, Welt CK, et al. Agenetic basis for functional hypothalamic amenorrhea. N Engl J Med. 2011;364:215-225.
21. Welt CK, Chan JL, Bullen J, et al. Recombinant human leptin in women with hypothalamic amenorrhea. N Engl J Med. 2004;351: 987-997.
22. Chou SH, Chamberland JP, Liu X, et al. Leptin is an effective treatment for hypothalamic amenorrhea. Proc Natl Acad Sci USA. 2011; 108:6585-6590.
23. Lucas AR, Beard CM, O'Fallon WM, Kurland LT. 50-Year trends in the incidence of anorexia nervosa in Rochester, MN: a population-based study. Am J Psychiatry. 1991;148:917-922.
24. Robergeau K, Joseph J, Silber TJ. Hospitalization of children and adolescents for eating disorders in the State of New York. J Adolesc Health. 2006;39:806-810.
25. Semple RK, Achermann JC, Ellery J, et al. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2005;90: 1849-1855.
26. Han TS, Bouloux PM. What is the optimal therapy for young males with hypogonadotropic hypogonadism? Clin Endocrinol (Oxf). 2010;72:731-737.
27. Lofrano-Porto A, Barra GB, Giacomini LA, et al. Luteinizing hormone β mutation and hypogonadism in men and women. N Engl J Med. 2007;357:897-904.
28. Layman LC, Lee EJ, Peak DB, et al. Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone β-subunit gene. N Engl J Med. 1997;337:607-611.
29. Layman LC, Porto AL, Xie J, et al. FSH β gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J Clin Endocrinol Metab. 2002;87:3702-3707.
30. Bhasin S, Cunningham GR, Hayes FJ, et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2010;95:2536-2559.
31. Lewkowitz-Shpuntoff HM, Hughes VA, Plummer L, et al. Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab. 2012;97:E136-E144.
32. Zacharin M, Sabin MA, Nair VV, Dagabdhao P. Addition of recombinant follicle-stimulating hormone to human chorionic gonadotropin treatment in adolescents and young adults with hypogonadotropic hypogonadism promotes normal testicular growth and may promote early spermatogenesis. Fertil Steril. 2012;98:836-842.
33. Barrio R, de Luis D, Alonso M, Lamas A, Moreno JC. Induction of puberty with human chorionic gonadotropin and follicle-stimulating hormone in adolescent males with hypogonadotropic hypogonadism. Fertil Steril. 1999;71:244-248.
34. Thau RB, Goldstein M, Yamamoto Y, Burrow GN, Phillips D, Bardin CW. Failure of gonadotropin therapy secondary to chorionic gonadotropin-induced antibodies. J Clin Endocrinol Metab. 1988; 66:862-867.
35. Delemarre EM, Felius B, Delemarre-van de Waal HA. Inducing puberty. Eur J Endocrinol. 2008;159(suppl 1):S9-S15.
36. Segal TY, Mehta A, Anazodo A, Hindmarsh PC, Dattani MT. Role of gonadotropin-releasing hormone and human chorionic gonadotropin stimulation tests in differentiating patients with hypogonadotropic hypogonadism from those with constitutional delay of growth and puberty. J Clin Endocrinol Metab. 2009;94:780-785.
37. Coutant R, Biette-Demeneix E, Bouvattier C, et al. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J Clin Endocrinol Metab. 2010;95:5225-5232.
38. Raivio T, Falardeau J, Dwyer A, et al. Reversal of idiopathic hypogonadotropic hypogonadism. N Engl J Med. 2007;357:863-873.
39. Cunningham GR, Toma SM. Clinical review: why is androgen replacement in males controversial? J Clin Endocrinol Metab. 2011; 96:38-52.
40. Swerdloff R, Wang C. Testosterone treatment of older men-why are controversies created? J Clin Endocrinol Metab. 2011;96:62-65.
41. Trarbach EB, Teles MG, Costa EM, et al. Screening of autosomal gene deletions in patients with hypogonadotropic hypogonadism using multiplex ligation-dependent probe amplification: detection of a hemizygosis for the fibroblast growth factor receptor 1. Clin Endocrinol (Oxf). 2010;72:371-376.
42. Shaw ND, Seminara SB, Welt CK, et al. Expanding the phenotype and genotype of female GnRH deficiency. J Clin Endocrinol Metab. 2011;96:E566-E576.
43. Sykiotis GP, Hoang XH, Avbelj M, et al. Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 2010; 95(6):3019-3027.